Alexis Rodríguez Gallego
Clinical Pharmacology specialist
Clinical Pharmacology specialist. He has a master’s degree in Bioethics and Law and is a member of the CEIm (Comité de Ética de Investigación con medicamentos) of the Hospital Vall d’Hebrón in Barcelona.
Atanasio Pandiella
Professor of Research at the Centro de Investigación del Cáncer of Salamanca.
His training includes research at the CNR, Ospedale San Raffaele in Milán and the Memorial Sloan Kettering Cancer Center in New York. His research focuses on the functional characterization of molecules involved in different human solid tumors, in particular breast tumors.
Ana Janic
Group Leader at Universidad Pompeu Fabra
Graduated from the University of Belgrade and PhD in Biomedicine from IRB-Barcelona. She is currently Professor Tenure-Track at the Universidad Pompeu Fabra of Barcelona, where she studies how tumor suppressors protect us from the development of cancer.
Oriol Casanovas
Group Leader at IBIDELL
Researcher of recognized international prestige with extensive knowledge and experience in basic and translational research of murine models of cancer and tumor angiogenesis. His scientific studies have been published in highly regarded journals in the cancer field.
Aranzazu Fernández
Medical Oncologist
Post-doctoral research associate in the laboratory run by Charles M.Perou at the UNC Lineberg Comprehensive Cancer Center. Her research interest is focused on Breast Cancer Genomic Biomarkers.
Violeta Serra
Group Leader of the VHIO Experimental Therapies Group
PhD from the University of Newcastle and postdoctoral stays in Charité, Berulon and CNIO. She is currently the principal investigator of the VHIO Experimental Therapies Group, where she studies the identification of biomarkers response to targeted therapies in breast cancer.
José Rios
Coordinator of the Medical Statistics Platform of IDIBAPS-Hospital Clínic of Barcelona.
More than 25 years of experience in statistical-methodological support with more than 200 indexed papers. He currently coordinates the medical statistical platform of IDIBAPS-Hospital Clínic and is an associate professor at the Faculty of Medicine of the UAB. He also collaborates with independent research groups like SOLTI.
Dolors Soy Muner
Head of Pharmacy at Hospital Clínic
PhD in Pharmacy from the Universidad de Barcelona and specialist in Hospital Pharmacy. She is an associate professor at the Faculty of Pharmacy of the Universidad de Barcelona while continuing her research. Her main lines of research focus on knowledge of the dose-concentration-effect relationships of drugs.
Orland Diez
Senior Researcher of the Hereditary Cancer Group of VHIO
PhD in Biology, physician at the Clinical and Molecular Genetics Area of the Hospital Universitario Vall d’Hebron and Senior Researcher of the Hereditary Cancer Group of the Vall d’Hebron Instituto Oncológico (VHIO).
Manel Esteller
Director of the Instituto de Investigación contra la Leucemia Josep Carreras
PhD of Medicine and Surgery from the Universidad de Barcelona. He is currently Director of the Instituto de Investigación contra la Leucemia Josep Carreras (IJC), research professor at ICREA and Tenured Full Professor of genetics at the School of Medicine of the Universidad de Barcelona. Author of more than 500 scientific publications and awarded among others with the Severo Ochoa Award and the Genetics and Oncology National Awards. His research focuses on the epigenetic mechanisms responsible for human disease, mainly cancer.
Patricia Villagrasa
Scientific Director of the Grupo Académico de Investigación Clínica y Traslacional en Cáncer SOLTI.
PhD in Molecular Biology and Biochemistry from the Universidad Autónoma de Barcelona. After more than 10 years in cancer research, she joined SOLTI in 2013 after a postdoctoral period at Columbia University (New York, USA) focused on breast cancer. Currently, she is the Scientific Director of the Grupo Académico de Investigación Clínica y Traslacional en Cáncer SOLTI, where she coordinates all operations and the scientific team, which supports the design and management of clinical trials for all researchers in the group.
Oscar Salamanca
Managing Director of APICES
Pharmacist and MBA from the Instituto de Empresa. With more than 25 years of experience in the drug research and development sector and with extensive management experience in the field of clinical research in CROs (Contract Research Organizations) and in the Oncology area. He is currently Managing Director of APICES (European CRO).
Judith Balmaña
Group Leader of the Hereditary Cancer Genetics Group in the Medical Oncology Service at VHIO
She specialized as a medical oncologist and is currently Head of the Hereditary Cancer Genetics Group in the Medical Oncology Service at the Hospital Universitario Vall d’Hebron and at the Vall d’Hebron Insitut d’Oncologia (VHIO). Her research areas cover the genetic epidemiology of hereditary breast and ovarian cancer, the clinical and psychological impact of genetic testing, and the clinical development of targeted therapies for patients with hereditary breast cancer.
Claudia Arnedo
PhD student at the Biomedical Genomics laboratory (IRB)
Graduated in Biomedical Sciences from the Universidad de Barcelona. In 2018, she obtained a Master's degree in Bioinformatics for Health Sciences from the Universidad Pompeu Fabra. She is currently carrying out her doctoral thesis in the Biomedical Genomics laboratory (IRB), led by Dr. Núria López Bigas, studying cancer driver mutations.
Toni Hurtado
Researcher at the Biosciences Department, Faculty of Medicine (University of Barcelona)
PhD at the Vall d’Hebron Institut de Recerca In late 2011, he became a group leader at the Norwegian Center for Molecular Medicine. He recently joined the Department of Biosciences at the Faculty of Medicine (Universidad de Barcelona), where he has focused on investigating the mechanisms related to the response to anti-ER drugs in breast tumors growth.
